Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risk factors for endometrial hyperplasia: results from a case-control study.

E Ricci1, S Moroni, F Parazzini

  • 1Mario Negri Institute of Pharmacological Research, University of Milan, Via Eritrea 62, 20157 Milan, Italy.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|June 13, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pregnancy outcomes and antiretroviral treatment in a national cohort of pregnant women with HIV: overall rates and differences according to nationality.

BJOG : an international journal of obstetrics and gynaecology·2007
Same author

Moderate alcohol drinking and risk of preterm birth.

European journal of clinical nutrition·2003
Same author

Fertility drugs and breast and ovarian cancer.

Lancet (London, England)·1995
Same author

Cancer mortality in Europe, 1990-92.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·1995
Same author

[Trends in skin cancers in the Vaud canton, 1976-1992].

Revue medicale de la Suisse romande·1995
Same author

Trends of skin cancer in the Canton of Vaud, 1976-92.

British journal of cancer·1995
Same journal

Corrigendum to "Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners" [International Journal of Gynecological Cancer 36 (2026) 104753].

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same journal

piR-hsa-8111406 promotes proliferation and serves as a novel biomarker for early detection of ovarian cancer: a multi-center retrospective study.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same journal

Poly(adenosine diphosphate-ribose) polymerase inhibitor maintenance therapy with niraparib in patients with primary advanced or recurrent endometrial cancer receiving dostarlimab plus chemotherapy.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same journal

Balancing fertility potential and oncologic and obstetric risks: a vignette study on decision-making in fertility-sparing surgery for early-stage cervical cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same journal

Updated pocket guide for integrated risk stratification in endometrial carcinoma: a practical tool based on European Society of Gynecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology 2025 guidelines.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same journal

How long is enough? Immunotherapy duration in mismatch repair deficient endometrial cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
See all related articles

Higher education, obesity, diabetes, and hormone replacement therapy (HRT) use are linked to an increased risk of endometrial hyperplasia (EH) in women. Postmenopausal status and later menopause onset also correlate with higher EH risk.

Area of Science:

  • Gynecology
  • Epidemiology
  • Reproductive Health

Background:

  • Endometrial hyperplasia (EH) is a condition affecting women's reproductive health.
  • Understanding risk factors for EH is crucial for early detection and prevention.

Purpose of the Study:

  • To analyze the epidemiologic characteristics of women at risk for endometrial hyperplasia (EH).

Main Methods:

  • A case-control study was conducted involving 129 women with confirmed EH and 258 controls.
  • Data on education, obesity, diabetes, parity, induced abortions, menopausal status, and hormone replacement therapy (HRT) use were collected and analyzed.

Main Results:

  • Higher education (OR > 12 years: 2.8), obesity (OR 2.7), and diabetes (OR 2.4) were significantly associated with increased EH risk.

Related Experiment Videos

  • Postmenopausal women had a lower risk of EH (OR 0.2) compared to premenopausal women.
  • Late menopause onset (age ≥ 53: OR 2.2) and HRT use in postmenopausal women (OR 3.1) increased EH risk.

    • Conclusions:

    • High education, obesity, diabetes, and HRT use are identified as significant risk factors for endometrial hyperplasia.
    • Menopausal status and age at menopause onset are important factors influencing EH risk.